Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 104 clinical trials
Low-dose CT-based Method for Detection of Subclinical Anthracycline-induced Cardiotoxicity

Prospective single arm study to evaluate a low-dose CT-based protocol for early detection of myocardial dysfunction in 50 cancer patients undergoing anthracycline-based chemotherapy.

primary cancer
bilateral oophorectomy
anthracyclines
  • 1 views
  • 25 Jan, 2021
  • 1 location
Anthracycline Induced Cardiotoxicity - Early Detection by Combination of Diastolic Strain and T2-mapping

. The aim of this study is to demonstrate that dose-dependent anthracycline-induced cardiotoxicity has a measurable effect on T2 mapping on MRI. The second aim is to demonstrate if the combination of

cancer
early detection
breast cancer
doxorubicin
cancer treatment
  • 0 views
  • 23 Jan, 2021
  • 1 location
Nab-paclitaxel and Alpelisib for the Treatment of Anthracycline Refractory Triple Negative Breast Cancer With PIK3CA or PTEN Alterations

anthracycline chemotherapy (anthrocycline refractory). Drugs used in chemotherapy, such as nab-paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them

cancer
progesterone
serum total bilirubin
estrogen receptor
primary tumor
  • 0 views
  • 24 Jan, 2021
  • 1 location
  • 0 views
  • 07 Aug, 2021
  • 3 locations
Avelumab + Paclitaxel/ Ramucirumab (RAP) as Second Line Treatment in Gastro-esophageal Adenocarcinoma

anthracycline, docetaxel or trastuzumab

thromboplastin
adenocarcinoma
avelumab
phenprocoumon
aptt
  • 0 views
  • 22 Jan, 2021
  • 1 location
Effect of Remote Ischaemic Conditioning in Oncology Patients

Cancer survival has improved steadily due to earlier detection and treatment. Despite the established efficacy of anthracycline chemotherapy, its damaging effects on the heart (cardiotoxicity

  • 0 views
  • 24 Jan, 2021
  • 1 location
Treatment of Milademetan Versus Trabectedin in Patient With Dedifferentiated Liposarcoma

resection is deemed to cause unacceptable morbidity or mortality) or metastatic DD liposarcoma that progressed on 1 or more prior systemic therapies, including at least 1 anthracycline-based therapy.

cancer
platelet count
liposarcoma
cancer chemotherapy
trabectedin
  • 0 views
  • 04 Sep, 2021
  • 1 location
Imaging Markers of Subclinical Cardiotoxicity in Breast Cancer

This research study is evaluating the use of Cardiac Magnetic Resonance Imaging (CMR) as a method of detecting early signs of damage to the heart that can be associated with anthracycline-based

carcinoma
anthracyclines
breast carcinoma
  • 0 views
  • 17 Feb, 2021
Study of Coronary Calcium Score as a Marker of Post-radiation Vascular Dysplasia in Adults Treated During Childhood for Cancer With Mediastinal Irradiation

To measure coronary calcium score in adults treated during childhood or adolescence for irradiation cancer in the heart and / or anthracycline area and compare them to determine whether

hypertension
doxorubicin
diabetes
anthracyclines
obesity
  • 0 views
  • 22 Jan, 2021
Calorie Restriction With or Without Metformin in Triple Negative Breast Cancer

anthracycline-taxane chemotherapy in patients with stage I-III TNBC

cancer
taxane
bilateral oophorectomy
progesterone
hysterectomy
  • 7 views
  • 25 Jan, 2021
  • 1 location